Grint Paul C Insider Trades

Insider Trading History

Track insider trading activity for Grint Paul C. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $49.8k 30,000 shares
Last Trade
Jul 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.2k 30,000 shares
$1.54
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $11.1k 6,667 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.1k 6,667 shares
$3.61
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $66.4k 40,000 shares
Last Trade
Jun 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.6k 40,000 shares
$0.81
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $37.6k 22,677 shares
Last Trade
Jun 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66.2k 22,677 shares
$2.92
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $11.3k 6,825 shares
Last Trade
Dec 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $0 0 shares
Last Trade
Dec 22, 2020 Sale
No data
No data
$1.66
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Executive Officer
Holding Value $4.61k 599 shares
Last Trade
Dec 08, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$629 599 shares
$1.05
$7.69
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Executive Officer
Holding Value $1.46M 190,076 shares
Last Trade
Sep 07, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$173k 190,076 shares
$0.91
$7.69
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Executive Officer
Holding Value $2.19M 285,113 shares
Last Trade
Sep 07, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$259k 285,113 shares
$0.91
$7.69
Regulus Therapeutics
Regulus Therapeutics RGLS
President & CEO
Holding Value $3.35M 410,000 shares
Last Trade
Feb 15, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59M 410,000 shares
$144.00
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President & CEO
Holding Value $1.06M 130,000 shares
Last Trade
Jan 30, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.3M 130,000 shares
$156.00
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President & CEO
Holding Value $1.52M 186,640 shares
Last Trade
Oct 05, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$78.8M 186,640 shares
$422.40
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President & CEO
Holding Value $2.16M 265,000 shares
Last Trade
Feb 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$202M 265,000 shares
$762.00
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President & CEO
Holding Value $245k 30,000 shares
Last Trade
Dec 16, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.7M 30,000 shares
$1,056.00
$8.16
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Director
Holding Value $125k 16,200 shares
Last Trade
Nov 05, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$915k 16,200 shares
$56.49
$7.69
Regulus Therapeutics
Regulus Therapeutics RGLS
President & CEO
Holding Value $4.08M 500,000 shares
Last Trade
Jun 25, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$613M 500,000 shares
$1,226.40
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Medical Officer
Holding Value $415k 50,870 shares
Last Trade
Dec 02, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$108M 50,870 shares
$2,131.20
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Medical Officer
Holding Value $326k 40,000 shares
Last Trade
Oct 20, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.7M 40,000 shares
$818.40
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Chief Medical Officer
Holding Value $2.04M 250,000 shares
Last Trade
Jun 16, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$227M 250,000 shares
$909.60
$8.16
Illumina
Illumina ILMN
Director
Holding Value $1.41M 8,365 shares
Last Trade
Jan 03, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.4k 295 shares
$55.55
$168.06

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up